Litfulo (Ritlecitinib) for Alopecia Areata: An Honest Guide
Litfulo is one of the genuinely big recent developments in hair medicine: a once-daily oral capsule (ritlecitinib, made by Pfizer) approved for severe alopecia areata in adults and adolescents from age 12, the autoimmune condition that causes patchy to total hair loss. It belongs to the new JAK inhibitor class that has transformed the outlook for severe cases. Here is what it is, who it is for, what the trials actually showed, and where it sits in the UK, without the hype.
Key takeaways
- Litfulo (ritlecitinib) is an oral JAK inhibitor for severe alopecia areata, approved by the FDA in 2023, and available in the UK, where NICE has recommended it for severe cases.
- It calms the autoimmune attack on follicles rather than stimulating growth directly.
- In trials, meaningful scalp regrowth took months, with a significant minority achieving major recovery by 6 to 12 months.
- It is for alopecia areata specifically, not pattern baldness.
- Specialist prescribing and monitoring are part of the deal, this is serious medicine for a serious condition.
What alopecia areata is, briefly
Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, pausing them and causing smooth patches, up to total scalp loss (alopecia totalis) or whole-body loss (alopecia universalis). The follicles usually survive, which is why regrowth is possible when the attack is calmed. The emotional weight of the condition is real and well documented, and severe cases historically had few good options, our alopecia areata guide covers the condition in full.
How Litfulo works
Ritlecitinib blocks specific Janus kinase (JAK) enzymes in the signalling chain the immune attack runs on. Interrupt the signal, and the inflammation around follicles subsides, giving paused follicles the chance to restart. This is cause-level treatment for the autoimmune attack, which is what makes the JAK class different from everything before it. (Its sibling in the class, deuruxolitinib, is covered in our CTP-543 guide.)
What the trials showed, honestly
In the pivotal trial of people with severe alopecia areata (at least 50% scalp loss), a meaningful minority, roughly a quarter of patients on the standard dose, achieved 80%+ scalp coverage within about six months, with numbers improving further over a year. Read that both ways: life-changing regrowth for many, and not a guarantee for everyone. Results build over months, not weeks, and continuing treatment maintains them.
Side effects and monitoring
Common effects include headaches, diarrhoea, acne and upper respiratory infections, generally mild. As an immune-modulating medicine, it also carries class warnings (infection risk among them) that are exactly why dermatologists screen and monitor patients rather than handing out capsules. If you are eligible, your specialist will walk through your personal risk picture, that conversation is the treatment's real front door.
Litfulo in the UK
Litfulo is approved in the UK, and NICE has recommended it for severe alopecia areata, a landmark, as the first treatment of its kind recommended for NHS use in this condition. The route: GP, dermatology referral, specialist assessment of severity and suitability. Private dermatology is the faster parallel path, our consultation guide covers preparing for that appointment.
Where gentle hair care fits
Alongside any alopecia areata treatment, regrowing hair arrives fine and fragile, and a gentle, sulphate-free wash routine treats it kindly while it thickens. Worth knowing: Watermans' Grow Me shampoo once featured in a widely read Daily Mail story about an alopecia sufferer's regrowth journey, a lovely story, and we will say plainly what the paper could not: no shampoo treats autoimmune disease. Gentle care supports the scalp and the returning hair; medicine addresses the attack.
A gentle, sulphate-free UK-made wash with biotin, caffeine and rosemary, kind daily care for a sensitive scalp and fine regrowing hair, alongside whatever you and your dermatologist decide.
Shop Grow MeWatermans is a UK family business that has sold over 5 million bottles since 2012. This article is informational, Litfulo decisions belong with a dermatologist.
Frequently asked questions
Is Litfulo a cream or a tablet?
A once-daily oral capsule. It is not a topical treatment, descriptions of rubbing it into the scalp are simply wrong.
Who can take Litfulo?
Adults and adolescents from 12 with severe alopecia areata, as assessed and prescribed by a dermatologist.
How long does Litfulo take to work?
Visible regrowth typically builds from around month 3, with trial endpoints measured at 6 months and improvement continuing over a year.
Does Litfulo work for male pattern baldness?
No, it targets the autoimmune attack of alopecia areata. Pattern loss runs on hormones and has its own treatments, per our pattern hair loss guide.
Is Litfulo available on the NHS?
NICE has recommended it for severe alopecia areata, making NHS access possible via dermatology referral, your GP is the starting point.
For severe alopecia areata, Litfulo represents something the condition waited decades for: a treatment aimed at the cause, with real trial results behind it. If that is your situation, the dermatology referral is the step that matters, and while the medicine does its slow work, treat the returning hair gently. It has been through enough.
%20approved%20for%20severe%20alopecia%20areata%20in%20adults%20and%20adolescents%20from...){kind=link}